In this episode, Dr. Marc Hedrick, CEO of Plus Therapeutics, shares his journey from academia to the biotech industry, discussing the innovative work being done in targeted radiotherapeutics for difficult-to-treat cancers. He elaborates on the importance of diagnostics in cancer treatment, the challenges of navigating the FDA approval process, and the complexities of scaling and manufacturing radiotherapeutic drugs. Dr. Hedrick also reflects on his motivations and the potential impact of their work on patient lives.

Plus Therapeutics Website https://plustherapeutics.com/

Nano Cap Podcast Website https://www.nanocappod.com/